| Hans-Günter Meyer-Thompson | International
USA. Significant barriers to care for patients seeking medication for opioid use
USA. Significant barriers to care for patients seeking medication for opioid use
Boston, MA – Buprenorphine-naloxone (buprenorphine), a highly effective, evidence-based treatment for opioid use disorder (OUD), is difficult to access in states with high rates of death associated with OUD, according to new research led by Harvard T.H. Chan School of Public Health. The study also found that access to buprenorphine is especially challenging among patients with Medicaid coverage. (Harvard Chan School of Public Health, USA, 03.06.2019)